New combo attack on advanced prostate cancer shows promise in early trial
NCT ID NCT07172685
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 31 times
Summary
This study is testing whether adding a focused ultrasound treatment to standard hormone therapy and chemotherapy can better control advanced prostate cancer that has spread to other parts of the body. The trial will enroll 116 men with high-tumor-burden metastatic hormone-sensitive prostate cancer. The goal is to see how long it takes for PSA levels to rise again, indicating the cancer is progressing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Qilu hospital
RECRUITINGJinan, Shandong, 276600, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.